$AGRI
AGRIFORCE GROWING SYSTEMS LTD. Stock $agri

$agri Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-Q Financial Statement

#000149315224019561 Filed on May 15, 2024

Income Statement

Concept	2024 Q1	2023 Q1
Revenue	$0.00	$0.00
YoY Change
Cost Of Revenue	$38.47K
YoY Change
Gross Profit	-$38.47K
YoY Change
Gross Profit Margin
Selling, General & Admin	$320.4K	$436.3K
YoY Change	-26.56%	-80.61%
% of Gross Profit
Research & Development	$3.585K	$36.12K
YoY Change	-90.08%	-90.89%
% of Gross Profit
Depreciation & Amortization	$167.0K	$168.8K
YoY Change	-1.04%	4680.74%
% of Gross Profit
Operating Expenses	$324.0K	$472.5K
YoY Change	-31.42%	-82.88%
Operating Profit	-$1.347M	-$2.822M
YoY Change	-52.27%	2.25%
Interest Expense	-$1.310M	-$1.879M
YoY Change	-30.31%	2812.87%
% of Operating Profit
Other Income/Expense, Net	-$260.9K	$2.981M
YoY Change	-108.75%	-752.2%
Pretax Income	-$3.328M	-$1.720M
YoY Change	93.47%	-47.58%
Income Tax
% Of Pretax Income
Net Earnings	-$3.300M	-$1.700M
YoY Change	94.12%	-48.19%
Net Earnings / Revenue
Basic Earnings Per Share	-$0.26	-$0.07
Diluted Earnings Per Share	-$0.26	-$0.07
COMMON SHARES
Basic Shares Outstanding	12.65M shares	18.16M shares
Diluted Shares Outstanding	12.65M shares	474.6K shares

Balance Sheet

Concept	2024 Q1	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$2.863M	$2.732M
YoY Change	4.81%	-37.6%
Cash & Equivalents	$2.863M	$2.732M
Short-Term Investments
Other Short-Term Assets	$395.3K	$520.5K
YoY Change	-24.06%	7.63%
Inventory
Prepaid Expenses	$262.0K	$383.6K
Receivables	$47.17K	$26.32K
Other Receivables	$47.17K	$26.32K
Total Short-Term Assets	$3.306M	$3.279M
YoY Change	0.82%	-32.87%
LONG-TERM ASSETS
Property, Plant & Equipment	$4.604K	$115.0K
YoY Change	-96.0%	-97.11%
Goodwill
YoY Change
Intangibles	$12.27M	$12.94M
YoY Change	-5.18%
Long-Term Investments	$218.5K
YoY Change
Other Assets	$79.69K	$0.00
YoY Change
Total Long-Term Assets	$12.68M	$16.60M
YoY Change	-23.62%	202.92%
TOTAL ASSETS
Total Short-Term Assets	$3.306M	$3.279M
Total Long-Term Assets	$12.68M	$16.60M
Total Assets	$15.99M	$19.88M
YoY Change	-19.59%	91.81%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$616.5K	$125.6K
YoY Change	390.85%	-54.4%
Accrued Expenses	$900.0K	$298.0K
YoY Change	201.99%	-45.27%
Deferred Revenue	$29.82K
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$2.071M	$4.267M
YoY Change	-51.47%
Total Short-Term Liabilities	$4.038M	$5.353M
YoY Change	-24.55%	204.02%
LONG-TERM LIABILITIES
Long-Term Debt	$44.28K	$44.34K
YoY Change	-0.14%	-7.66%
Other Long-Term Liabilities	$2.964M	$6.275M
YoY Change	-52.76%	78.96%
Total Long-Term Liabilities	$3.009M	$6.320M
YoY Change	-52.39%	77.79%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.038M	$5.353M
Total Long-Term Liabilities	$3.009M	$6.320M
Total Liabilities	$7.047M	$11.67M
YoY Change	-39.63%	119.6%
SHAREHOLDERS EQUITY
Retained Earnings	-$47.84M	-$34.49M
YoY Change	38.68%
Common Stock	$53.88M	$31.28M
YoY Change	72.23%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$8.939M	$8.209M
YoY Change
Total Liabilities & Shareholders Equity	$15.99M	$19.88M
YoY Change	-19.59%	91.81%

Cashflow Statement

Concept	2024 Q1	2023 Q1
OPERATING ACTIVITIES
Net Income	-$3.300M	-$1.700M
YoY Change	94.12%	-48.19%
Depreciation, Depletion And Amortization	$167.0K	$168.8K
YoY Change	-1.04%	4680.74%
Cash From Operating Activities	-$1.300M	-$2.600M
YoY Change	-50.0%	-9.43%
INVESTING ACTIVITIES
Capital Expenditures		$0.00
YoY Change		-100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$281.4K	$3.108M
YoY Change	-90.95%
NET CHANGE
Cash From Operating Activities	-$1.300M	-$2.600M
Cash From Investing Activities
Cash From Financing Activities	$281.4K	$3.108M
Net Change In Cash	-$1.015M	$462.7K
YoY Change	-319.39%
FREE CASH FLOW
Cash From Operating Activities	-$1.300M	-$2.600M
Capital Expenditures		$0.00
Free Cash Flow		-$2.600M
YoY Change		9.67%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	A1
CY2024Q1	us-gaap	Inventory Net InventoryNet		usd
CY2024Q1	us-gaap	Common Stock Shares Authorized Unlimited CommonStockSharesAuthorizedUnlimited	Unlimited
CY2023	us-gaap	Common Stock Shares Authorized Unlimited CommonStockSharesAuthorizedUnlimited	Unlimited
CY2024Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	us-gaap	Inventory Write Down InventoryWriteDown		usd
CY2023Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2024Q1	AGRI	Write Off Of Deposit WriteOffOfDeposit		usd
CY2024Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation		usd
CY2023Q1	AGRI	Stock Issued During Period Value Conversion Of Vested Prefunded Warrants StockIssuedDuringPeriodValueConversionOfVestedPrefundedWarrants		usd
CY2024Q1	AGRI	Shares Issued For Compensation And Bonuses SharesIssuedForCompensationAndBonuses		usd
CY2023Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2023Q1	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1		usd
CY2024Q1	AGRI	Write Off Of Deposit WriteOffOfDeposit		usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories		usd
CY2023Q1	AGRI	Increase Decrease In Lease Deposit Asset IncreaseDecreaseInLeaseDepositAsset		usd
CY2023Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability		usd
CY2024Q1	AGRI	Increase Decrease In Rightofuse Asset IncreaseDecreaseInRightofuseAsset		usd
CY2024Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability		usd
CY2023Q1	AGRI	Initial Fair Value Of Debenture Warrants Fifth Tranche Warrants InitialFairValueOfDebentureWarrantsFifthTrancheWarrants		usd
CY2023Q1	AGRI	Initial Fair Value Of Conversion Feature Of Debentures Fifth Tranche Debentures InitialFairValueOfConversionFeatureOfDebenturesFifthTrancheDebentures		usd
CY2024Q1	us-gaap	Construction In Progress Expenditures Incurred But Not Yet Paid ConstructionInProgressExpendituresIncurredButNotYetPaid		usd
CY2024Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods		usd
CY2024Q1	us-gaap	Operating Lease Cost OperatingLeaseCost		usd
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2024Q1	dei	Entity File Number EntityFileNumber	001-40578
CY2024Q1	dei	Entity Registrant Name EntityRegistrantName	AGRIFORCE GROWING SYSTEMS LTD.
CY2024Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2024Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2024Q1	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2024Q1	dei	Entity Shell Company EntityShellCompany	false
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	26036516	shares
CY2024Q1	us-gaap	Cash Cash	2863391	usd
CY2023Q4	us-gaap	Cash Cash	3878578	usd
CY2023Q4	AGRI	Lease Deposit Noncurrent Assets LeaseDepositNoncurrentAssets	63708	usd
CY2023Q4	AGRI	Construction In Progress ConstructionInProgress	113566	usd
CY2023Q4	us-gaap	Investments And Other Noncurrent Assets InvestmentsAndOtherNoncurrentAssets	223801	usd
CY2023Q4	us-gaap	Assets Assets	17367927	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1942011	usd
CY2023Q4	us-gaap	Secured Debt Current SecuredDebtCurrent	4084643	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	15336	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	6041990	usd
CY2023Q4	us-gaap	Lease Deposit Liability LeaseDepositLiability	25684	usd
CY2023Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	2690308	usd
CY2023Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	45365	usd
CY2023Q4	us-gaap	Liabilities Liabilities	8803347	usd
CY2024Q1	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2023Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	22573938	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	22573938	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5841045	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5841045	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	49828942	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	3472444	usd
CY2023Q4	AGRI	Obligation To Issue Shares ObligationToIssueShares	97094	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-44507304	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-326596	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	8564580	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	17367927	usd
CY2023Q4	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1:50 reverse stock split
CY2024Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	388604	usd
CY2023Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	915534	usd
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	295202	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	335761	usd
CY2024Q1	us-gaap	Professional Fees ProfessionalFees	170392	usd
CY2023Q1	us-gaap	Professional Fees ProfessionalFees	287366	usd
CY2024Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	166998	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	168760	usd
CY2024Q1	AGRI	Consulting Fees Or Expenses ConsultingFeesOrExpenses	102915	usd
CY2023Q1	AGRI	Consulting Fees Or Expenses ConsultingFeesOrExpenses	209115	usd
CY2024Q1	AGRI	Shareholder And Regulatory ShareholderAndRegulatory	55964	usd
CY2023Q1	AGRI	Shareholder And Regulatory ShareholderAndRegulatory	70395	usd
CY2024Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	44170	usd
CY2023Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	76080	usd
CY2024Q1	us-gaap	Inventory Write Down InventoryWriteDown	38470	usd
CY2024Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	25340	usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	281491	usd
CY2024Q1	AGRI	Investor And Public Relations InvestorAndPublicRelations	25280	usd
CY2023Q1	AGRI	Investor And Public Relations InvestorAndPublicRelations	267918	usd
CY2024Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	25228	usd
CY2023Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	100578	usd
CY2024Q1	AGRI	Travel And Entertainment TravelAndEntertainment	4683	usd
CY2023Q1	AGRI	Travel And Entertainment TravelAndEntertainment	72644	usd
CY2024Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3585	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	36123	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-1346831	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-2821765	usd
CY2024Q1	AGRI	Accretion Interest On Debentures AccretionInterestOnDebentures	1364205	usd
CY2023Q1	AGRI	Accretion Interest On Debentures AccretionInterestOnDebentures	1872470	usd
CY2024Q1	AGRI	Gain Loss On Conversion Of Convertible Debt GainLossOnConversionOfConvertibleDebt	-272732	usd
CY2023Q1	AGRI	Gain Loss On Conversion Of Convertible Debt GainLossOnConversionOfConvertibleDebt	-419703	usd
CY2024Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-410433	usd
CY2024Q1	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-23769	usd
CY2023Q1	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	3374032	usd
CY2024Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	54631	usd
CY2023Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-6620	usd
CY2024Q1	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	4252	usd
CY2023Q1	AGRI	Write Off Of Deposit WriteOffOfDeposit	12000	usd
CY2024Q1	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	39891	usd
CY2023Q1	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	38473	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-3327700	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1720053	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-279905	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	114886	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-3607605	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1605167	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.26
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.26
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.62
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-3.62
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12650304	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12650304	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	474573	shares
CY2024Q1	us-gaap	Accounts Payable And Other Accrued Liabilities AccountsPayableAndOtherAccruedLiabilities	421308	usd
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	474573	shares
CY2023Q4	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1:50 reverse stock split
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	8564580	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	3973437	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	25000	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	-15969	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-3327700	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-279905	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	8939443	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	10542653	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	10542653	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	1048573	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	105512	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	27735	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	-2085960	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	175979	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1720053	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	114886	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	8209325	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	8209325	usd
CY2023Q4	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1:50 reverse stock split
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-3327700	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1720053	usd
CY2024Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	166998	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	168760	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	-15969	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	175979	usd
CY2024Q1	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	25000	usd
CY2023Q1	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	27735	usd
CY2023Q1	AGRI	Shares Issued For Compensation And Bonuses SharesIssuedForCompensationAndBonuses	105512	usd
CY2024Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1238955	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1738825	usd
CY2024Q1	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-23769	usd
CY2023Q1	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	3374032	usd
CY2024Q1	AGRI	Gain Loss On Conversion Of Convertible Debt GainLossOnConversionOfConvertibleDebt	-272732	usd
CY2023Q1	AGRI	Gain Loss On Conversion Of Convertible Debt GainLossOnConversionOfConvertibleDebt	-419703	usd
CY2024Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-410433	usd
CY2024Q1	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-4252	usd
CY2023Q1	AGRI	Write Off Of Deposit WriteOffOfDeposit	12000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	16307	usd
CY2023Q1	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-22621	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	122405	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-65810	usd
CY2024Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-38470	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-4180	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-294655	usd
CY2024Q1	AGRI	Increase Decrease In Lease Deposit Asset IncreaseDecreaseInLeaseDepositAsset	18382	usd
CY2024Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	15000	usd
CY2023Q1	AGRI	Increase Decrease In Rightofuse Asset IncreaseDecreaseInRightofuseAsset	43784	usd
CY2023Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-39862	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1309334	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2647873	usd
CY2024Q1	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	1000000	usd
CY2023Q1	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	4615385	usd
CY2024Q1	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	668568	usd
CY2023Q1	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	1180950	usd
CY2024Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	50000	usd
CY2023Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	325962	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	281432	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3108473	usd
CY2024Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations	12715	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations	2130	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1015187	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	462730	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	3878578	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2269320	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2863391	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2732050	usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet	32370	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	133645	usd
CY2024Q1	AGRI	Initial Fair Value Of Debenture Warrants Fifth Tranche Warrants InitialFairValueOfDebentureWarrantsFifthTrancheWarrants	564000	usd
CY2024Q1	AGRI	Initial Fair Value Of Conversion Feature Of Debentures Fifth Tranche Debentures InitialFairValueOfConversionFeatureOfDebenturesFifthTrancheDebentures	359000	usd
CY2024Q1	AGRI	Shares Issued For Conversion Of Convertible Debt SharesIssuedForConversionOfConvertibleDebt	3973437	usd
CY2023Q1	AGRI	Shares Issued For Conversion Of Convertible Debt SharesIssuedForConversionOfConvertibleDebt	1048573	usd
CY2023Q1	us-gaap	Construction In Progress Expenditures Incurred But Not Yet Paid ConstructionInProgressExpendituresIncurredButNotYetPaid	39875	usd
CY2024Q1	us-gaap	Nature Of Operations NatureOfOperations	<p id="xdx_80D_eus-gaap--NatureOfOperations_zRWVLOSWMNMj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1. <span id="xdx_829_zlyxCz8KyTE8">NATURE OF OPERATIONS AND BASIS OF PREPARATION</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Business Overview</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AgriFORCE Growing Systems Ltd. (“AgriFORCE™” or the “Company”) was incorporated as a private company by Articles of Incorporation issued pursuant to the provisions of the <i>Business Corporations Act (British Columbia)</i> on December 22, 2017. The Company’s registered and records office address is at 800 – 525 West 8<sup>th</sup> Avenue, Vancouver, British Columbia, Canada, V5Z 1C6.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is an innovative agriculture-focused technology company that delivers reliable, financially robust solutions for high value crops through our proprietary facility design and automation Intellectual Property to businesses and enterprises globally through our AgriFORCE™ Solutions division (“Solutions”) and delivers nutritious food products through our AgriFORCE™ Brands division (“Brands”). During 2023, the Company launched its UN(THINK) Awakened Flour™ flour, which is a nutritious flour that provides many health advantages over traditional flour.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Solutions intends to operate in the plant based pharmaceutical, nutraceutical, and other high value crop markets using its unique proprietary facility design and hydroponics based automated growing system that enable cultivators to effectively grow crops in a controlled environment (“FORCEGH+™”). The Company has designed FORCEGH+™ facilities to produce in virtually any environmental condition and to optimize crop yields to as near their full genetic potential possible whilst substantially eliminating the need for the use of pesticides and/or irradiation. The Company also has a global license to sell and distribute hydroxyl devices. During 2023, the Company completed sales and deliveries of its hydroxyl devices.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brands is focused on the development and commercialization of plant-based ingredients and products that deliver healthier and more nutritious solutions. We will market and commercialize both branded consumer product offerings and ingredient supply.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Basis of Presentation</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying Unaudited Condensed Consolidated Interim Financial Statements and related financial information of AgriFORCE Growing Systems Ltd. should be read in conjunction with the audited financial statements and the related notes thereto for the years ended December 31, 2023 and 2022 included in the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission (“SEC”) on April 1, 2024. These unaudited interim financial statements have been prepared in accordance with the rules and regulations of the United States Securities and SEC for interim financial information. Accordingly, they do not include all of the information and footnotes required by the accounting principles generally accepted in the United States of America (“U.S. GAAP”) for complete financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the opinion of management, the accompanying interim financial statements contain all adjustments which are necessary to state fairly the Company’s financial position as of March 31, 2024 and December 31, 2023, and the results of its operations and cash flows during the three months ended March 31, 2024 and 2023. Such adjustments are of a normal and recurring nature. The results for the three months ended March 31, 2024 are not necessarily indicative of the results to be expected for the full fiscal year ending December 31, 2024, or for any future period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Liquidity and Management’s Plan</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has incurred substantial operating losses since its inception and expects to continue to incur significant operating losses for the foreseeable future. As reflected in the interim financial statements for the three months ended March 31, 2024, the Company had a net loss of $<span id="xdx_90F_eus-gaap--NetIncomeLoss_pn5n6_di_c20240101__20240331_zQkeBOmleUKh" title="Net loss">3.3</span> million, $<span id="xdx_908_eus-gaap--NetCashProvidedByUsedInOperatingActivities_pn5n6_di_c20240101__20240331_zmJBICkgTSz9" title="Net cash used in operating activities">1.3</span> million of net cash used in operating activities, and the Company had a working capital deficit of $<span id="xdx_90D_ecustom--WorkingCapitalDeficit_iI_pn5n6_c20240331_ztcGbW8T5lsg" title="Working captial deficit">0.7</span> million.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying interim financial statements have been prepared on a going concern basis, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. The interim financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might result from the outcome of this uncertainty. The Company is at the development stage of its business plan. As such it is likely that additional financing will be needed by the Company to fund its operations and to develop and commercialize its technology. These factors raise substantial doubt about the Company’s ability to continue as a going concern. For the next twelve months from issuance of these interim financial statements, the Company will seek to obtain additional capital through the sale of debt or equity financings or other arrangements to fund operations; however, there can be no assurance that the Company will be able to raise needed capital under acceptable terms, if at all. The sale of additional equity may dilute existing shareholders and newly issued shares may contain senior rights and preferences compared to our currently outstanding common shares. If the Company is unable to obtain such additional financing, future operations would need to be scaled back or discontinued. Due to the uncertainty in the Company’s ability to raise capital, management believes that there is substantial doubt in the Company’s ability to continue as a going concern for twelve months from the issuance of these interim financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Reverse Stock Split</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On October 11, 2023, the Company executed a one-for-fifty reverse stock split of the Company’s common shares (the “Reverse Split”). As a result of the Reverse Split, every 50 shares of the Company’s old common shares were converted into one share of the Company’s new common shares. Fractional shares resulting from the reverse split were rounded up to the nearest whole number. The Reverse Split automatically and proportionately adjusted all issued and outstanding shares of the Company’s common shares, as well as convertible debentures, convertible features, prefunded warrants, stock options and warrants outstanding at the time of the date of the Reverse Split. The exercise price on outstanding equity based-grants was proportionately increased, while the number of shares available under the Company’s equity-based plans was proportionately reduced. Share and per share data (except par value) for the periods presented reflect the effects of the Reverse Split. References to numbers of common shares and per share data in the accompanying financial statements and notes thereto for periods ended prior to October 11, 2023 have been adjusted to reflect the Reverse Split on a retroactive basis.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-3300000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1300000	usd
CY2024Q1	AGRI	Working Capital Deficit WorkingCapitalDeficit	700000	usd
CY2023Q4	us-gaap	Other Assets OtherAssets	10555	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	395277	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	272872	usd
CY2024Q1	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p id="xdx_842_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zojoLKUuBXAf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_862_zpfmHoHhT4G6">Reclassifications</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has reclassified certain share base payment expenses from <i>Wages and salaries</i> to <i>Share based compensation</i> in the 2023 consolidated statements of comprehensive loss to align with the 2024 presentation.</span></p>
CY2024Q1	AGRI	Legal Retainer LegalRetainer	10517	usd
CY2023Q4	AGRI	Legal Retainer LegalRetainer	8039	usd
CY2024Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	262033	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	223624	usd
CY2024Q1	AGRI	Inventory Advances InventoryAdvances	118697	usd
CY2023Q4	AGRI	Inventory Advances InventoryAdvances	30654	usd
CY2024Q1	us-gaap	Other Assets OtherAssets	4030	usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	38857	usd
CY2023	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	141175	shares
CY2024Q1	AGRI	Unconverted Prefunded Warrants Outstanding UnconvertedPrefundedWarrantsOutstanding	6425	shares
CY2023Q4	AGRI	Unconverted Prefunded Warrants Outstanding UnconvertedPrefundedWarrantsOutstanding	6425	shares
CY2024Q1	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P20Y
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	490634	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	654179	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	654179	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	654179	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	654179	usd
CY2024Q1	AGRI	Finite Lived Intangible Assets Amortization Expense After Year Four FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour	9158506	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	12265856	usd
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	616491	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	578128	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	900032	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	868451	usd
CY2023Q4	us-gaap	Accounts Payable And Other Accrued Liabilities AccountsPayableAndOtherAccruedLiabilities	495432	usd
CY2024Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1937831	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1942011	usd
CY2023Q3	us-gaap	Debt Instrument Convertible Threshold Trading Days DebtInstrumentConvertibleThresholdTradingDays	5	integer
CY2024Q1	us-gaap	Debt Instrument Interest Rate Terms DebtInstrumentInterestRateTerms	The First, Second, Third, Fourth and Fifth Tranche Debentures (the “Debentures”) have an interest rate of 5% for the first 12 months, 6% for the subsequent 12 months, and 8% per annum thereafter. Principal repayments will be made in 25 equal installments which began on September 1, 2022 for the First Tranche Debentures, July 1, 2023 for the Second Tranche Debentures, January 1, 2024 for the Third Tranche Debentures, May 1, 2024 for the Fourth Tranche Debentures and August 1, 2024 for the Fifth Tranche Debentures. The Debentures may be extended by nine months at the election of the Company by paying a sum equal to nine months’ interest on the principal amount outstanding at the end of the 18th month, at the rate of 8% per annum.
CY2024Q1	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	5869877	usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	7385494	usd
CY2024Q1	us-gaap	Secured Debt Current SecuredDebtCurrent	2070745	usd
CY2023Q4	us-gaap	Secured Debt Current SecuredDebtCurrent	4084643	usd
CY2024Q1	AGRI	Accretion Interest On Debentures AccretionInterestOnDebentures	1364205	usd
CY2023Q1	AGRI	Accretion Interest On Debentures AccretionInterestOnDebentures	1872470	usd
CY2024Q1	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	668568	usd
CY2023Q1	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	1180950	usd
CY2024Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	29815	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	15336	usd
CY2023Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	2690308	usd
CY2024Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases	923000	usd
CY2024Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements	-630106	usd
CY2024Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease	23769	usd
CY2024Q1	AGRI	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Effect Of Exchange Rate Changes FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodEffectOfExchangeRateChanges	-67675	usd
CY2024Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	2939296	usd
CY2022Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	4649115	usd
CY2023Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases	3977000	usd
CY2023Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements	-111597	usd
CY2023Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease	-3374032	usd
CY2023Q1	AGRI	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Effect Of Exchange Rate Changes FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodEffectOfExchangeRateChanges	-73810	usd
CY2023Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	5066676	usd
CY2024Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	45755522	shares
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	505583	shares
CY2023Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	72643	usd
CY2024Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	44170	usd
CY2023Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	3437	usd
CY2024Q1	us-gaap	Lease Cost LeaseCost	44170	usd
CY2023Q1	us-gaap	Lease Cost LeaseCost	76080	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	3497073	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	3541549	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	902000	usd
CY2024Q1	us-gaap	Long Term Debt LongTermDebt	7940622	usd
CY2023Q3	us-gaap	Loss Contingency Damages Sought Value LossContingencyDamagesSoughtValue	451684	usd
CY2023Q3	us-gaap	Loss Contingency Damages Awarded Value LossContingencyDamagesAwardedValue	230000	usd
CY2024Q1	us-gaap	Loss Contingency Damages Sought Value LossContingencyDamagesSoughtValue	467249

Files In Submission

Name	View Source	Status
0001493152-24-019561-index-headers.html	Edgar Link	pending
0001493152-24-019561-index.html	Edgar Link	pending
0001493152-24-019561.txt	Edgar Link	pending
0001493152-24-019561-xbrl.zip	Edgar Link	pending
agri-20240331.xsd	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
form10-q_001.jpg	Edgar Link	pending
form10-q_002.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
agri-20240331_def.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
agri-20240331_cal.xml	Edgar Link	unprocessable
agri-20240331_lab.xml	Edgar Link	unprocessable
agri-20240331_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AGRI
AGRIFORCE GROWING SYSTEMS LTD. Stock $agri

2024 Q1 Form 10-Q Financial Statement

#000149315224019561 Filed on May 15, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AGRI AGRIFORCE GROWING SYSTEMS LTD. Stock $agri

2024 Q1 Form 10-Q Financial Statement

#000149315224019561 Filed on May 15, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AGRI
AGRIFORCE GROWING SYSTEMS LTD. Stock $agri